Literature DB >> 2669154

Efficacy of prophylactic antibiotics for the prevention of endomyometritis after forceps delivery.

J A Heitmann1, G I Benrubi.   

Abstract

The purpose of this prospective randomized controlled clinical trial was to determine whether prophylactic antibiotics reduce the incidence of endomyometritis after forceps delivery. Of the 393 patients studied, 192 received 2 gm of intravenous cefotetan after forceps delivery, and 201 patients received no antibiotics. There were seven cases of endomyometritis in the group given no antibiotic and none in the cefotetan group, a statistically significant difference (P less than .01). We conclude that prophylactic antibiotics are effective in reducing the incidence of endomyometritis after forceps delivery. We believe this is the first published study demonstrating this benefit.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2669154     DOI: 10.1097/00007611-198908000-00007

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  3 in total

Review 1.  Antibiotic prophylaxis for operative vaginal delivery.

Authors:  Tippawan Liabsuetrakul; Thanapan Choobun; Krantarat Peeyananjarassri; Q Monir Islam
Journal:  Cochrane Database Syst Rev       Date:  2017-08-05

2.  Antibiotic prescribing in women during and after delivery in a non-teaching, tertiary care hospital in Ujjain, India: a prospective cross-sectional study.

Authors:  Megha Sharma; Linda Sanneving; Kalpana Mahadik; Michele Santacatterina; Suryaprakash Dhaneria; Cecilia Stålsby Lundborg
Journal:  J Pharm Policy Pract       Date:  2013-11-04

3.  Prophylactic antibiotics in the prevention of infection after operative vaginal delivery (ANODE): a multicentre randomised controlled trial.

Authors:  Marian Knight; Virginia Chiocchia; Christopher Partlett; Oliver Rivero-Arias; Xinyang Hua; Kim Hinshaw; Derek Tuffnell; Louise Linsell; Edmund Juszczak
Journal:  Lancet       Date:  2019-05-13       Impact factor: 79.321

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.